Efficacy and safety of the SoniCracker intravascular lithotripsy device for severely calcified coronary lesions: the LEAD-FIM study from China

Haiwei Liu, Jiancheng Xiu, Qin Qin, Ziliang Bai, Qian Tong, Shaobin Jia, Ping Zhang, Jun Zhang, Zhixiong Zhong, Wei Liu, Yong He, Quanmin Jing, Yaling Han · 2025

Read Efficacy and safety of the SoniCracker intravascular lithotripsy device for severely calcified coronary lesions: the LEAD-FIM study from China by Haiwei Liu, Jiancheng Xiu, Qin Qin, Ziliang Bai, Qian Tong, Shaobin Jia, Ping Zhang, Jun Zhang, Zhixiong Zhong, Wei Liu, Yong He, Quanmin Jing, Yaling Han (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12888462.txt.

Description

Haiwei Liu and colleagues reported in 2025 the LEAD-FIM trial from China, a first test of the SoniCracker lithotripsy device. Hard, calcified deposits make it hard to open narrowed coronary arteries and place stents. Sound-wave lithotripsy inside the vessel can crack that calcium first, and the trial checked whether a new system could do so safely.

More than one hundred and eighty patients with severely calcified lesions were treated at eleven sites. Nearly all procedures met the success target of a well-placed stent with little remaining narrowing and no major heart event in the first week. Imaging in a subgroup showed wider vessel openings after treatment, and no serious device-related harms were recorded.

Catalog record

CREATORHaiwei Liu, Jiancheng Xiu, Qin Qin, Ziliang Bai, Qian Tong, Shaobin Jia, Ping Zhang, Jun Zhang, Zhixiong Zhong, Wei Liu, Yong He, Quanmin Jing, Yaling Han
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12888462

Browse the full library · About the Tower of Babel